secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2026-04-01T23:59:59+00:00
Accession:  0001193125-26-135660
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bruker appoints QIAGEN CEO Thierry Bernard to Board of Directors
----------------------------------------------------------------

- Thierry L. Bernard appointed to Bruker's Board effective April 1, 2026; board expanded to 12 directors.
- Bernard is CEO of QIAGEN N.V. (NYSE: QGEN), set to step down upon successor appointment; brings life-science tools expertise.
- He previously served 15 years at bioMérieux including Corporate VP Global Commercial Operations, Investor Relations, and Greater China.
- Bernard also sits on Neogen Corporation (NASDAQ: NEOG) board and chairs AdvaMedDx trade association.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000119312526135660/0001193125-26-135660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000119312526135660/brkr-20260401.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-135660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer